Medtronic (NYSE: MDT) made a significant neurovascular play earlier this month when it agreed to acquire Scientia Vascular.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results